SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VD's Model Portfolio & Discussion Thread

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Cytokine1 who wrote (2071)8/21/1997 5:55:00 PM
From: Vector1   of 9719
 
CYTO, with Rman on vaca I have to make some unilateral moves. Henry is going to like this. We are going to sell 4400 shares of CYTO at the close of 4.125 and buy another 1000 shares of LGND at 12.5. After seeing GLFD move on the AMGN announcement it promtped me on how the market will react to a major diabetes deal. It also frees up some cash to buy some other stocks that we have been discussing. Under consederation are new names such as MCDE, DURA, VISX, TGEN and SEPR. I am also considering shorting GERN if the stock gets back to 13. I am interested in everyones views.
I have not totally given up on CYTO but from a fund management standpoint I could not see continuing to overweight the stock so heavily. I think QUAD will eventually be a big winner but I think the ramp will be slow and I think there will be dilution at an unfortunate valuation because the company is running out of cash. Management has not been confidence inspiring.
V1
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext